logo
AI Icon𝛼SK or Search
ENTITY
Jacobio Pharmaceuticals

Jacobio Pharmaceuticals (1167 HK)

83
Analysis
Health Care • China
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the in-house discovery and development of innovative oncology therapies, focusing on "undruggable" targets in key oncogenic pathways. They leverage their Induced Allosteric Molecule Discovery Platform and iADC Platform to develop novel drugs, including clinical-stage candidates like Glecirasib (KRAS G12C inhibitor) and Sitneprotafib (SHP2 inhibitor) for various solid tumors. The company was founded in 2015 and is headquartered in Beijing, China.
more
Company Event • 09 Mar 2027 16:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 24 Aug 2026 20:40 • Upcoming
Add To Calendar

H1 2026

Company Event • 10 Mar 2026 16:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 29 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 19 Mar 2025 20:46 • Upcoming
Add To Calendar

H2 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x